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Substudies of the Childhood AsthmaManagement Program [Con-
trol. Clin. Trials 20 (1999) 91–120; N. Engl. J. Med. 343 (2000)
1054–1063] seek to identify patient characteristics associated with
asthma symptoms and lung function. To determine if genetic mea-
sures are associated with trajectories of lung function as measured
by forced vital capacity (FVC), children in the primary cohort study
retrospectively had candidate loci evaluated. Given participant bur-
den and constraints on financial resources, it is often desirable to
target a subsample for ascertainment of costly measures. Methods
that can leverage the longitudinal outcome on the full cohort to se-
lectively measure informative individuals have been promising, but
have been restricted in their use to analysis of the targeted subsam-
ple. In this paper we detail two multiple imputation analysis strate-
gies that exploit outcome and partially observed covariate data on
the nonsampled subjects, and we characterize alternative design and
analysis combinations that could be used for future studies of pul-
monary function and other outcomes. Candidate predictor (e.g., IL10
cytokine polymorphisms) associations obtained from targeted sam-
pling designs can be estimated with very high efficiency compared to
standard designs. Further, even though multiple imputation can dra-
matically improve estimation efficiency for covariates available on all
subjects (e.g., gender and baseline age), relatively modest efficiency
gains were observed in parameters associated with predictors that
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are exclusive to the targeted sample. Our results suggest that future
studies of longitudinal trajectories can be efficiently conducted by use
of outcome-dependent designs and associated full cohort analysis.
1. Introduction. The Childhood AsthmaManagement Program [CAMP;
CAMP Research Group (1999 and 2000)] was a randomized clinical trial that
compared two anti-inflammatory medications and a placebo on lung growth
over the course of 4 years in children with mild to moderate asthma. CAMP
substudies have since examined the relationship between genetic factors and
asthma phenotypes. Like other genetic data collected in CAMP, interleukin-
10 (IL10) genotype data were obtained retrospectively by analysis of stored
blood samples. IL10 is a type-2 T-helper cytokine with anti-inflammatory
properties, and polymorphisms in the IL10 cytokine gene have been shown
to be associated with asthma phenotypes in children [Lyon et al. (2004)].
However, as is often the case, ascertainment of expensive exposures can
restrict sample size and therefore motivate thoughtful sampling strategies.
Given that the outcome of interest was available on all subjects, we seek
to determine whether the longitudinal response could or should be used to
target a subset of select individuals for sampling of covariates. In particu-
lar, we explore both sampling designs and associated analysis options with
the goal of providing recommendations for the efficient conduct of future
retrospective studies.
We are specifically interested in the impact genetic variants have on both
lung function and growth, and on the effect of medication (versus placebo)
within subgroups defined by genetic variants of the IL10 gene. For nearly all
children, forced vital capacity (FVC, a measure of lung function) was mea-
sured ten times over the course of 4 years, thereby providing rich detail on
the primary response trajectory. Our scientific question can be addressed by
appropriate longitudinal regression models with a focus on estimating the
main effects of time since randomization, time-invariant randomized treat-
ment assignment (Budesonide, Nedocromil, placebo), and their interactions
with the presence or absence of at least one IL10 polymorphism. Valid IL10
and other data were available for 555 children who participated in CAMP.
Even though all data were available for these children, we will illustrate
the interplay between sampling strategies and analysis procedures by as-
suming study resources are limited and IL10 data can only be collected on
approximately 250 children. The assumption of limited resources allows us to
compare and contrast several sampling designs and estimation procedures in
order to inform decisions when conducting similar substudies in the future.
In related work, Neuhaus, Scott and Wild (2002, 2006) discussed biased,
outcome dependent sampling (ODS) designs with longitudinal response data
and estimation from resulting data using a profile likelihood. In the longi-
tudinal binary response setting, Schildcrout and Heagerty (2008, 2011) de-
scribed stratified sampling designs based on the sum of the response series
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with an ascertainment corrected likelihood approach for analysis. Schild-
crout and Rathouz (2010), Schildcrout et al. (2012) and Neuhaus et al.
(2014) addressed auxiliary variable dependent sampling where the sampling
variable is related but is not equal to the longitudinal response. In the uni-
variate continuous response setting, Zhou et al. (2002, 2007) and Weaver
and Zhou (2005) discussed ODS designs that combine simple random sam-
ples with a sample of subjects whose responses are more extreme. Further,
several authors discussed unplanned outcome-dependent follow-up for lon-
gitudinal continuous response data [e.g., Lin and Ying (2001), Lipsitz et al.
(2002), B
◦
uzˇkova´ and Lumley (2009)].
In Schildcrout, Garbett and Heagerty (2013), we proposed biased epi-
demiological study designs for continuous longitudinal response data where
sampling is based on strata defined by low-dimensional summaries of the
response series. We proposed sampling based on the intercept, the slope, or
both the intercept and slope of the subject-specific ordinary least squares
(OLS) regressions of the response on a time-varying covariate (which may
be time itself). We showed that sampling based on a variable related to a
target predictor can lead to substantial efficiency gains relative to random
sampling for the associated parameter. Such a result is well known to survey
sampling methodologists [e.g., see Kish (1965), Korn and Graubard (2011)].
The estimation procedure discussed in Schildcrout, Garbett and Heagerty
(2013) used a bias correcting, ascertainment corrected conditional likelihood
that only includes subjects with fully observed exposure data (i.e., those who
were sampled). Such an analysis can be referred to as a complete data (CD)
analysis [Carroll et al. (2006), Lawless, Kalbfleisch and Wild (1999)]. In uni-
variate response settings, such as the case-cohort design, other authors [e.g.,
Breslow et al. (2009a, 2009b), Marti and Chavance (2011)] have shown that
utilizing the partial data on the unsampled subjects can add information
and improve estimation efficiency.
With specific motivation from the CAMP study, the purpose of this
manuscript is to detail the joint impact of sampling design and statisti-
cal analysis decisions toward efficient parameter estimation with longitu-
dinal continuous response data. Longitudinal outcome-dependent sampling
designs have only recently been proposed, and analysis options have not
considered use of both sampled and unsampled subjects. Using the CAMP
study for motivation and illustration, we focus on the following goals: (1)
to evaluate circumstances under which multiple imputation (MI) increases
efficiency appreciably over the bias-correcting complete data (CD) analy-
sis under ODS designs, and (2) to evaluate the extent to which the ODS
designs improve estimation efficiency when MI (rather than CD analysis)
is the chosen analytical approach. We use a simulation study to explore
relative efficiency across several sampling design and estimation procedure
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combinations. The CAMP study is an exemplar of a longitudinal random-
ized trial in which retrospective collection of additional explanatory data is
conducted to in order to leverage the original cohort study and answer new
scientific questions. The CAMP data provide an ideal context to inform ef-
ficient study design options for future ancillary studies of factors associated
with longitudinal outcome trajectories.
Section 2 discusses the model of interest, briefly reviews the sampling
strategy and estimation procedure discussed in Schildcrout, Garbett and
Heagerty (2013), and proposes two multiple imputation analysis strategies
that exploit the unsampled subjects’ data. Section 3 examines the relative
efficiency of design and analysis procedures in a number of plausible scenar-
ios. Section 4 returns to the CAMP data to examine the impact of study
designs on the FVC data, and Section 5 provides a discussion including
directions for future research.
2. Methodological framework. We now introduce the mixed model, the
class of ODS designs and associated CD analyses, and two multiple impu-
tation (MI) extensions for conducting analyses.
2.1. Linear mixed effects model for continuous longitudinal response data.
With N subjects in the original cohort, Yi, i ∈ 1,2, . . . ,N , the ni-vector of
response values, Xi, a ni × p fixed effects design matrix, and Zi the ni × q
design matrix for the random effects, we begin with the Laird and Ware
(1982) linear mixed effects model given by
Yi =Xiβ+Zibi + εi,(2.1)
where β is a p-vector of fixed-effect coefficients, bi ∼ N(0,D), and εi ∼
N(0,Σ). A common design matrix for the random effects in the continuous
data setting is Zi = (1,Ti), where Ti is a time-varying covariate—perhaps
time itself, bi = (b0i, b1i), and Di is the 2 × 2 covariance matrix contain-
ing variance components (σ20 , σ
2
1) and correlation ρ= corr(b0i, b1i). Analysis
based on a random sample of Ns subjects can be conducted by maximizing
the log-likelihood
l(θ;Y,X) =
Ns∑
i=1
li(θ;Yi,Xi) =
Ns∑
i=1
log f(Yi|Xi;θ),(2.2)
where θ = (β, σ0, σ1, ρ) and f(·) is the multivariate normal density function.
2.2. Coarsened summary sampling designs. Study designs proposed in
Schildcrout, Garbett and Heagerty (2013) propose subsampling from a larger
cohort based on a user defined, low-dimensional summary of the outcome
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vector Yi or, more accurately, on strata defined by the summary mea-
sure. Let Xoi be a covariate subset of Xi that is known prior to initia-
tion of the substudy and let Qi = g(Yi,Xoi) be any function of the re-
sponse and observed covariates that summarizes important features of the
response vectors. Three simple and useful summaries are the estimated
intercept, slope, and the joint intercept and slope, based on the subject-
specific OLS regression of Yi on a time-varying covariate. For example,
if Ti is the easily ascertained time-varying covariate, Xti = (1,Ti) ⊂Xoi,
and Woi = (X
t
tiXti)
−1Xtti, then Qi =WoiYi is the estimated intercept and
slope for the regression ofYi on Ti. We proposed stratified random sampling
based on regions of Qi. Based on results from other literature [e.g., Zhou et
al. (2002, 2007, 2011)], we oversampled the extremes of the Qi distribution
to realize substantial efficiency gains for target parameters. Let Si equal 1
if subject i is sampled for exposure ascertainment and 0 if not. For region
Rk ∈ {R1, . . . ,RK}, let pi(Rk) = pr(Si = 1|Yi,Xi) = pr(Si = 1|qi ∈ R
k) be
the probability of being sampled given qi, the observed value of Qi, is in
region k. Importantly, Si ⊥ (Yi,Xi)|qi, that is, sampling depends upon the
data (Yi,Xi) only through qi.
2.3. An ascertainment corrected likelihood for coarsened summary sam-
pling designs. For inferences to the population represented by the origi-
nal cohort—as opposed to the pseudo-population represented by the biased
sample—Schildcrout, Garbett and Heagerty (2013) considered maximization
of an ascertainment corrected likelihood (ACL). The ACL corrects for the
design by conditioning the likelihood on inclusion into the ODS (Si = 1). It is
a “complete data” (CD) likelihood [Carroll et al. (2006), Lawless, Kalbfleisch
and Wild (1999)] in that only subjects with complete exposure data con-
tribute to the conditional likelihood, and therefore to the analysis. A key
attraction of the CD approach is that valid inferences can be realized while
only requiring a model for Yi|Xi without requiring a model for Xi. Specif-
ically, if f(Yi|Xi;θ) is the density for subject i under simple random sam-
pling from a population, the density for those who are included in the ODS
is given by
f(Yi|Xi, Si = 1;θ)
= pi(qi)f(Yi|Xi;θ){pr(Si = 1|Xi;θ)}
−1(2.3)
= pi(qi)f(Yi|Xi;θ)
{
K∑
k=1
pi(Rk)
∫
Rk
f(qi|Xi;θ)dqi
}−1
,
where pi(qi) is subject i’s sampling probability that is based on qi [i.e.,
pi(qi) = pi(R
k) if and only if qi ∈R
k], pi(Rk) is the sampling probability for
all values of Qi in region R
k, and
∫
Rk
f(qi|Xi;θ)dqi = pr(qi ∈ R
k|Xi;θ).
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Because pi(qi) is parameter-free, being specified by the investigator, if a
total of Ns subjects are selected into the ODS for exposure ascertainment,
the ascertainment corrected log-likelihood, lC(θ;Y,X), is given by
l(θ;Y,X)−
Ns∑
i=1
log
{
K∑
k=1
pi(Rk)
∫
Rk
f(qi|Xi;θ)dqi
}
.(2.4)
In the special case whereQi =WoiYi is a linear transformation ofYi, un-
der the assumption Yi|Xi ∼ N(µi,Vi), then Qi|Xi ∼ N(µq,i,Vq,i), where
µq,i =Woiµi and Vq,i =WoiViW
t
oi. Thus, the ACL is a straightforward
extension of the likelihood used for standard analyses, and details can be
found in Schildcrout, Garbett and Heagerty (2013). We note that this log-
likelihood is composed of two terms: the standard log-likelihood as in equa-
tion (2.2) and an additive ascertainment correction piece that accounts for
the biased study design and is the probability of being sampled as a function
of Xoi. This is in contrast to inverse probability weighting or weighted like-
lihood approaches [e.g., Horvitz and Thompson (1952), Robins, Rotnitzky
and Zhao (1994)] that multiply the log-likelihood by a function of the sam-
pling probability to calculate an unbiased estimating equation.
2.4. Multiple imputation. Whereas the analysis procedures proposed in
Schildcrout, Garbett and Heagerty (2013) were more efficient than ran-
dom sampling, one can expect that there may be additional information
in those subjects for whom the unmeasured, expensive exposure, Xei, was
not ascertained (i.e., those with Si = 0). We therefore propose to multiply
impute [Rubin (1976)] Xei for all subjects in whom Si = 0. Multiple im-
putation (MI) is expected to recover some of the information about the
parameter associated with Xei that is lost by not measuring Xei, and it
is expected to recover much more of the information in parameters asso-
ciated with Xoi that is available but is not used in CD analyses. Multi-
ple imputation is attractive because it can leverage existing methods and
software without needing tailored programs. In the approaches described
below, we generate imputation samples from the conditional exposure dis-
tribution in unsampled subjects [Xei|Yi,Xoi, Si = 0]. Once the exposure
model is constructed, we build M multiple imputation data sets, fit the
target model to each one using standard maximum likelihood, and combine
estimates across imputations to make inferences regarding model param-
eters. For any parameter θ in θ, we may estimate its value and variance
with θ̂ =M−1
∑M
m=1 θ̂
(m) and V̂ar(θ̂) = V +(1+M−1)B, respectively, where
V =M−1
∑M
m=1 V̂ar(θ̂
(m)) and B = (M − 1)−1
∑M
m=1(θ̂
(m) − θ̂)2. With ad-
equate M , test statistics for parameters are well approximated by a stan-
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dard Gaussian distribution; however, with small M , a t-distribution with
df = (M −1)[1+MV /{(M +1)B}]2 degrees of freedom is more appropriate
[Rubin (1976), Little and Rubin (2002), Schafer and Graham (2002)]. In the
settings we believe our designs could be most useful, Xei is to be imputed
in a relatively large percentage of subjects (i.e., well over 50 percent), and
in such cases a larger number of imputation samples are required to use the
normal approximation to the t-distribution.
We now describe two approaches to estimating the imputation model
[Xei|yi,xoi, Si = 0]. The first is an extension of the CD analysis described
in Section 2.3 and the second is a direct imputation approach that does
not require estimation based on maximizing the ACL. Because the ODS
sampling schemes we have described depend upon the data through a low-
dimensional response summary and possibly observed covariates Xoi,
pr(xei|xoi,yi, Si = 0) = pr(xei|xoi,yi) = pr(xei|xoi,yi, Si = 1).(2.5)
Thus, the design-based “missing data mechanism” is ignorable and gener-
ating Xei for unsampled subjects can be based directly on model estimates
derived from sampled data without consideration of the biased sample. Im-
portantly, for the CAMP analysis, the missing exposure variable (Xei) was
binary and so for the present research, we only detail this special case ex-
plicitly; however, extensions to continuous and other exposure values are
feasible.
2.4.1. Imputation model construction: Combine response model and mar-
ginal exposure model. The complete data plus multiple imputation analysis
approach (CD+MI) combines the estimates from maximizing the ACL in
Section 2.3 with an exposure model for [Xei|xoi, Si = 1] to estimate [Xei|yi,
xoi, Si = 0]. Specifically, we combine a CD estimate of [Yi|xi, Si = 1] with
a covariate logistic regression for [Xei|xoi, Si = 1] to identify the conditional
exposure distribution [Xei|yi,xoi, Si = 1] used for imputation among those
with Si = 0. Using equation (2.5) and Bayes’ theorem,
pr(Xei = 1|xoi,yi, Si = 0)
pr(Xei = 0|xoi,yi, Si = 0)
(2.6)
=
f(yi|Xei = 1,xoi, Si = 1)
f(yi|Xei = 0,xoi, Si = 1)
·
pr(Xei = 1|xoi, Si = 1)
pr(Xei = 0|xoi, Si = 1)
.
Using the logistic regression model to obtain estimate p̂r(xei|xoi, Si = 1) in
the observed subjects’ data, and then combining it with f̂(yi|xei,xoi, Si = 1)
from the CD analysis, we are able to estimate and sample from p̂r(xei|xoi,yi,
Si = 0).
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Note. We may write the exposure odds model itself as
pr(Xei = 1|xoi, Si = 1)
pr(Xei = 0|xoi, Si = 1)
(2.7)
=
pr(Si = 1|Xei = 1,xoi)
pr(Si = 1|Xei = 0,xoi)
·
pr(Xei = 1|xoi)
pr(Xei = 0|xoi)
.
The first term on the right side of the equation is a ratio of the ascertainment
corrections for Xei = 1 and Xei = 0 that is shown in equation (2.3). We can
therefore use the log of the ratio of ascertainment corrections as an offset in
a logistic regression, marginal exposure model given by (2.7). In some cases,
such an approach may be more natural or simple than modeling the marginal
exposure model on the left side of equation (2.7) directly. This is due to
the fact that the marginal exposure model, pr(Xei|Xoi), may be simpler
in the population as compared to the observed sample, pr(Xei|Xoi, Si =
1). For example, in many realistic scenarios, one would expect that time-
varying and time-invariant covariates are independent in the population.
In the CAMP, time since randomization is expected to be independent of,
say, genotype. However, for the biased sample, such time-varying covariates
may be spuriously associated with genotype due to their impact on the
probability of being sampled. If one wished to model the left-hand side of
equation (2.7) directly, the functional forms of time-varying covariates must
be carefully considered.
The steps for creating the imputation data sets used in the CD+MI ap-
proach are as follows:
(1) On sampled subjects, Si = 1, maximize the ascertainment corrected log-
likelihood shown in equation (2.4) to obtain estimates θ̂ and uncertainty
Ĉov(θ̂) associated with the response model.
(2) For m= 1, . . . ,M , draw θ(m) from the approximate posterior distribu-
tion for θ̂ given by the normalized likelihood function, and calculate
(2a) f(yi|Xei = 1,xoi, Si = 1;θ
(m)){f(yi|Xei = 0,xoi, Si = 1;θ
(m))}−1,
(2b) log[pr(Si = 1|Xei = 1,xoi;θ
(m)){pr(Si = 1|Xei = 0,xoi;θ
(m)}−1].
(3) On sampled subjects, using (2b) as an offset, fit a logistic regression of
Xei on Xoi to obtain parameter (call it α) and uncertainty estimates
for the marginal exposure model shown in equation (2.7). Then, draw
α(m) from a N [α̂, Ĉov(α̂)] and calculate
(3a) pr(Xei = 1|xoi, Si = 1;α
(m)){pr(Xei = 0|xoi, Si = 1;α
(m))}−1.
(4) For unsampled subjects, multiply the results of (2a) and (3a) to calculate
the conditional exposure odds in equation (2.6) and then draw imputed
values, X
(m)
ei .
(5) Conduct standard maximum likelihood analysis on the response model
using the complete imputation data set.
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(6) Repeat steps (2)–(5) M times and combine results in the standard man-
ner.
To the extent that the assumptions of the response and marginal exposure
models are correct, the foregoing CD+MI approach is expected to be valid
and relatively efficient compared to the CD approach. It is worth noting
that the imputation model for the CD+MI approach is a general location
model that is discussed in, for example, Little and Schluchter (1985), Schafer
(2010), and Little and Rubin (2002).
2.4.2. Imputation model construction: Direct conditional exposure model.
Another approach to constructing the imputation model is relatively di-
rect and could employ available MI software. In contrast to CD+MI, it
decouples the imputation and the analysis models. We refer to it as direct
multiple imputation (D-MI) and it is a special case of multiple imputation
by chained equations [e.g., Raghunathan et al. (2001), White, Royston and
Wood (2011)] which is implemented in software packages such as MICE
[Van Buuren (2012)] in the R programming language [R Core Team (2013)].
We may ascertain and sample from [Xei|yi,xoi, Si = 0] directly by noting
that the conditional exposure odds model on the left-hand side of equation
(2.6) can be constructed using logistic regression analysis with any functions
of yi and xoi as independent variables. Since Xe,i ⊥ Si|(Yi,Xoi) by design,
then if the Gaussian linear mixed model assumptions are satisfied, the in-
duced conditional exposure log-odds from equation (2.6) can be written
−
1
2
{(Yi −µ1,i)
tV−11i (Yi −µ1,i)− (Yi −µ0,i)
tV−10i (Yi −µ0,i)}
(2.8)
−
1
2
log
{
|V1,i|
|V0,i|
}
+ log
{
pr(Xei = 1|Xoi)
pr(Xei = 0|Xoi)
}
,
where µx,i = E(Yi|Xei = x,xoi), Vx,i = Var(Yi|Xei = x,xoi) = ZiDxiZi +
σ2eI. If we assume homoscedasticity, then V1,i = V0,i = Vi, and equation
(2.8) simplifies to
YtiV
−1
i (µ1,i −µ0,i)︸ ︷︷ ︸
(a)
−
1
2
(µt1,iV
−1
i µ1,i −µ
t
0,iV
−1
i µ0,i)︸ ︷︷ ︸
(b)
(2.9)
+ log
{
pr(Xei = 1|Xoi)
pr(Xei = 0|Xoi)
}
︸ ︷︷ ︸
(c)
.
In the Supplement A [Schildcrout et al. (2015)], we detail further simplifi-
cations with balanced and complete data that we examine in Section 3 and
that are motivated by the CAMP analysis whose design was nearly balanced
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and complete. Briefly, with balanced and complete data, if νi,jk is the (j, k)th
element of V−1i and ωij(tij) is the xei effect at time tij (i.e., µ1,ij − µ0,ij),
(a) equals
∑n
j=1
∑n
k=1 νi,jk · yij · ωik(tik), (b) equals
∑n
j=1
∑n
k=1 νi,jk · µ0,ij ·
ωik(tik)+
∑n
j=1
∑n
k=1 νi,jk ·ωij(tij) ·ωik(tik), and (c) contains terms involving
xoi useful for predicting Xei. Our approach to imputation is then to directly
model [Xei|Xoi,Yi] with logistic regression and to follow standard multiple
imputation methods. We note that the first two terms in equations (2.8)
and (2.9), respectively, result in the functional form of quadratic and linear
discriminant analysis [Fisher (1936)] that are used in many classification
analyses.
3. Finite sampling operating characteristics. The key motivator in out-
come dependent sampling schemes is to obtain nearly efficient inference at
considerable cost savings by drawing and analyzing small to modest sample
sizes. Indeed, the CAMP study could have realized considerable savings if
it had only analyzed 250 genotypes, versus more than 500. As such, it is
critical in application of these design strategies to quantify the degree to
which theoretical results are realized in finite sample settings. Schildcrout,
Garbett and Heagerty (2013) conducted such simulations, that are briefly
summarized in the Introduction. We now examine the CD+MI and D-MI
estimation procedures proposed in Section 2 to explore: (1) the scenarios
under which MI does and does not improve estimation efficiency over a CD
analysis; and (2) the extent to which the study design continues to improve
efficiency if MI is the intended analytical strategy.
3.1. Population model. We conducted simulation studies under several
study designs and population features motivated by the CAMP study and
by studies with similarly-balanced longitudinal follow-up. Results presented
here summarize 1000 replications per scenario. In each scenario, we gener-
ated a cohort of N subjects based on the model
Yij = β0 + βttij + βggi + βgtgitij + βcci + b0i + b1itij + εij ,
with i ∈ {1,2, . . . ,N} denoting subject, j ∈ {1,2, . . . ,10} denoting observa-
tion within subject, tij an equally spaced, balanced time covariate ranging
from −2 to 2, Ci a binary, time-invariant covariate with pr(Ci = 1) = 0.5, Gi
an expensive, binary “group” or “genotype” variable with pr(Gi = 1|Ci =
c) = 0.4 + δcc, (bi0, bi1) the random intercept and slope, and εij the mea-
surement error. Across all scenarios, (β0, βt, βgt) = (5,1.0,0.75), the mean
of the random effects and error distributions were 0, and the standard
deviations of the random intercept, the random slope and the measure-
ment error were σ0 = 5, σ1 = 1.25 and σe = 5, respectively. Additionally,
ρ= corr(b0i, b1i) =−0.25.
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We examined the relative efficiency of the designs and estimation proce-
dures as a function of the following: the Gi effect size, βg ∈ {−2.5,−4.0},
the strength of the Gi ∼ Ci relationship, δc ∈ {0.15,0.35,0.55}, the sample
size of the original cohort N ∈ {750,2250}, and the impact of Ci being a
proxy for Gi as opposed to being a confounder for the Gi ∼ Yi relation-
ship. In the last scenario, βc = 0 and Ci is used to impute Gi but is not
included in the primary analysis model. In all other scenarios, βc = 1 and
Ci is included as an independent variable. Specifically, we examine five dis-
tinct scenarios uniquely identified by (N,βg, δc, βc). Scenarios studied are
given by the following: (a) (750,−2.5,0.15,1.0), (b) (750,−4.0,0.15,1.0), (c)
(750,−2.5,0.35,1.0), (d) (2250,−2.5,0.15,1.0), and (e) (750,−2.5,0.55,0.0).
3.2. Study designs. The substudies we sought to examine were those
that sampled, on average, 250 subjects for whom Gi should be ascertained,
again motivated by the CAMP framework. For the random sampling (RS)
design, we took a simple random sample of 250 subjects at each replication.
For ODS designs based on the intercept (ods.i), slope (ods.s), and bivariate
intercept and slope (ods.b), we calculated subject-specific intercepts and
slopes based on the N separate OLS regressions of the response Yij on time
tij , and sampled subject i with probability that depended upon the region
in which Qi was located. For ods.i and ods.s we split the distribution of
the sampling variable Qi into three regions defined by the 12th and 88th
percentiles of the population distribution. We then sampled individuals with
probability pi(qi) = pr(Si = 1|Qi = qi) so that, on average, 90 subjects from
each of the two outlying regions and 70 subjects from the central region were
included in the outcome dependent sample. Similarly for the ods.b design, we
sampled with probability so that 70 subjects were included from the central
rectangular region that contained 76 percent of the population and 180
subjects were included from the outlying region containing 24 percent of the
population. See Schildcrout, Garbett and Heagerty (2013) for a description
and a figure describing these sampling schemes.
3.3. Analyses. After subsampling from the original cohort of N , we con-
ducted the CD analysis by fitting the model with maximum ascertainment
corrected likelihood under the ODS designs or with standard maximum like-
lihood (ML) under the RS design. To conduct multiple imputation analyses,
we estimated the multiple imputation model for Gi in unsampled subjects
pr(Gi|yi, ci, Si = 0) via approaches discussed in Sections 2.4.1 and 2.4.2.
Specifically, the imputation model for CD+MI analyses was estimated by
combining the CD analysis and the offsetted logistic regression analysis of gi
on ci in sampled subjects. The imputation model for the D-MI approach was
estimated with a regression model of Gi on predictors
∑
j yij ,
∑
j yij · tij and
Ci in sampled subjects. See the online supplementary materials [Schildcrout
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et al. (2015)] for an explanation of why these independent variables were
used in the imputation model. The number M of imputation samples used
was based on examination of the degrees of freedom that were calculated
as described in Section 2.4 and with the intention of conducting sufficient
imputation analyses so that the t-statistics associated with all parameter es-
timates were well approximated by normal distributions for all parameters.
When N = 750, M = 25 was used; when N = 2250, M = 35.
3.4. Results. Because the models were properly specified, all estimation
procedures were observed to be approximately valid with observed biases
in parameter estimates less than 5% and observed biases in standard errors
less than 10% (not shown).
Table 1 shows the efficiency of each design and analysis procedure com-
bination relative to the RS design and standard CD maximum likelihood
analysis. Relative efficiency is defined as the empirical variance under RS
plus CD analyses divided by the empirical variance under each other design
and estimation procedure. Note that the CD+MI and D-MI approaches
perform similarly for nearly all parameter-by-scenario combinations. In sce-
nario (a) we observe that for βg and βgt the impact of the study design
far outweighs the impact of multiply imputing Gi. For example, using CD
analyses to estimate βgt, the ods.s design improves estimation efficiency by
87 percent over RS, but adding multiple imputation to the CD analysis by
using the CD+MI approach improves efficiency only by an additional 7.4
percent (2.01/1.87 = 1.074). However, if interest is in estimates of βc, which
correspond to Ci, a covariate that is available in everyone, the impact of
multiple imputation outweighs the study design. Notice that with both the
CD+MI and D-MI approaches all designs have a relative efficiency for βc
of approximately 2.6–2.7 compared to random sampling with CD analyses.
For estimates of β0 and βt, the study design and multiple imputation-based
analyses independently contributed to optimal estimation efficiency.
Scenarios (b), (c), (d) and (e) provide some insight into how the results
shown in scenario (a) depend upon population data features. We used these
scenarios specifically to examine the extent to which MI adds to the optimal
study design with CD analyses and we now focus our discussion exclusively
on βg and βgt. Comparing results from scenario (b) to (a), we observed
that the impact of MI is somewhat greater when the Gi effect size is larger.
Whereas in scenario (b), when estimating βg , CD+MI was 20 percent more
efficient than CD for the optimal ods.i design (1.99/1.65 = 1.20), in scenario
(a) it was only 4 percent more efficient (2.20/2.11 = 1.04). As shown by
comparing results from scenarios (c) and (d) to (a), we observe that MI
appears to add modest additional precision to the optimal design when the
Gi ∼Ci relationship is stronger and when the original cohort size is larger.
Finally, in scenario (e) we observed that when Ci is a proxy for Gi rather
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Table 1
Relative efficiency: Results show ratios of the empirical variance of the RS design with standard CD analyses to the empirical variance
of all other study design and analysis procedures across 1000 replicates. The designs ods.i, ods.s and ods.b are ODS designs with
sampling based on the intercept, slope, and both intercept and slope of subject-specific ordinary least squares regression of Yij on tij . For
each parameter we show columns that correspond to CD, CD+MI and D-MI analyses, respectively. In scenario ( e) we do not estimate
βc, as Ci is not included in the final model but is only used for Gi imputation
N , βg, δc, βc Design β0 βt βg βgt βc
(a) 750, −2.5, 0.15, 1.0 RS 1.00, 1.88, 1.90 1.00, 1.68, 1.64 1.00, 1.02, 1.03 1.00, 1.13, 1.09 1.00, 2.66, 2.65
ods.i 2.18, 2.63, 2.63 0.89, 1.37, 1.35 2.11, 2.20, 2.19 0.88, 0.94, 0.92 1.99, 2.64, 2.64
ods.s 1.02, 1.89, 1.90 2.01, 2.32, 2.27 1.00, 1.00, 1.02 1.87, 2.01, 1.96 1.03, 2.61, 2.62
ods.b 1.82, 2.42, 2.41 1.64, 1.97, 1.97 1.75, 1.79, 1.82 1.52, 1.59, 1.59 1.72, 2.67, 2.65
(b) 750, −4.0, 0.15, 1.0 RS 1.00, 1.90, 1.92 1.00, 1.65, 1.67 1.00, 1.20, 1.21 1.00, 1.14, 1.16 1.00, 2.65, 2.59
ods.i 1.79, 2.17, 2.14 1.02, 1.61, 1.57 1.65, 1.99, 1.96 1.01, 1.07, 1.04 1.83, 2.27, 2.20
ods.s 1.01, 1.85, 1.83 2.30, 2.71, 2.74 0.91, 1.06, 1.05 2.19, 2.35, 2.36 1.00, 2.49, 2.48
ods.b 1.57, 2.13, 2.10 2.03, 2.44, 2.42 1.43, 1.57, 1.57 1.85, 1.98, 1.93 1.79, 2.53, 2.46
(c) 750, −2.5, 0.35, 1.0 RS 1.00, 1.90, 1.91 1.00, 1.61, 1.51 1.00, 1.05, 1.04 1.00, 1.23, 1.15 1.00, 2.26, 2.27
ods.i 2.03, 2.62, 2.62 1.00, 1.56, 1.48 1.95, 2.09, 2.12 0.96, 1.15, 1.08 1.90, 2.37, 2.39
ods.s 1.13, 2.06, 2.05 2.10, 2.53, 2.53 1.01, 1.06, 1.07 2.07, 2.33, 2.33 1.00, 2.28, 2.28
ods.b 1.89, 2.51, 2.51 1.88, 2.28, 2.24 1.71, 1.81, 1.78 1.84, 2.02, 1.95 1.67, 2.45, 2.41
(d) 2250, −2.5, 0.15, 1.0 RS 1.00, 2.97, 3.01 1.00, 2.03, 2.00 1.00, 1.07, 1.07 1.00, 1.14, 1.11 1.00, 5.83, 5.79
ods.i 2.06, 4.69, 4.67 0.99, 1.97, 1.89 1.76, 2.01, 2.01 0.95, 1.11, 1.07 1.89, 5.75, 5.74
ods.s 0.98, 2.85, 2.89 2.12, 3.75, 3.70 0.92, 0.95, 0.97 2.05, 2.44, 2.39 0.86, 5.61, 5.52
ods.b 1.65, 3.98, 4.07 1.83, 3.25, 3.21 1.52, 1.57, 1.60 1.81, 2.02, 1.98 1.53, 5.76, 5.50
(e) 750, −2.5, 0.55, 0.0 RS 1.00, 1.71, 1.60 1.00, 1.79, 1.59 1.00, 1.50, 1.37 1.00, 1.52, 1.32
ods.i 1.95, 2.33, 2.33 1.03, 1.64, 1.49 1.98, 2.29, 2.29 0.92, 1.39, 1.20
ods.s 1.04, 1.65, 1.58 1.99, 2.36, 2.33 0.99, 1.46, 1.36 2.03, 2.37, 2.33
ods.b 1.77, 2.16, 2.09 1.80, 2.21, 2.17 1.75, 2.06, 1.96 1.77, 2.17, 2.08
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than a confounder and when the Gi ∼ Ci relationship is relatively strong
with δc = 0.55, adding MI to the optimal design led to larger efficiency gains
for βg and βgt. For example, the relative efficiency of CD+MI relative to CD
analyses for the optimal designs for βg and βgt were 2.29/1.98 = 1.16 and
2.37/2.03 = 1.17, respectively.
Multiple imputation resulted in substantial efficiency improvements over
CD analysis for estimates of (β0, βt, βc), but had a far smaller impact on
estimation efficiency for (βg, βgt). Figure 1 shows the relative efficiency for
estimating the mean value at the end of the study period for those with
(Gi,Ci) = (1,1), µ̂i,10 =E(Yij |Gi = 1,Ci = 1, tij = 2) under all scenarios. By
combining parameter estimates to obtain the linear predictor estimate we
observed that in all scenarios and for all study designs, CD+MI and D-
MI analyses are substantially more efficient than CD analyses. That is, MI
improved estimation efficiency dramatically, and the study design itself had a
more modest impact. However we also note that the ods.b design is the most
efficient design in all scenarios for estimating the end-of-study mean value.
Fig. 1. Relative efficiency for estimating the predicted value at the end of the study period
µi,10 = E(Yi,10|Gi = 1,Ci = 1, tij = 2) for all design and analysis procedure combinations
versus RS and standard CD analyses based on 1000 replications. Symbol o denotes CD
analyses, △ denotes CD+MI analyses, and + denotes D-MI analyses. Parameter values
(a)–(e) are given in Table 1.
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Even though ods.b was not the optimal design for any single parameter
(see Table 1), it is reasonably efficient for all parameters, which is beneficial
if more than one parameter is of interest. In contrast, the ods.s and ods.i
designs were efficient for individual parameters but were inefficient for other
parameters.
4. CAMP data analysis. In this section we analyze the CAMP data using
different subsampling designs both with and without imputation. Our goal
is to empirically compare the research efficiency of candidate designs, and we
have the complete data against which we can benchmark performance. Since
our simulation study showed that CD+MI and D-MI approaches are similar,
we focus our presentation on only one imputation approach (CD+MI). A
total of 555 subjects had sufficient covariate and genotype data available,
and we operate under the assumption that stored blood samples are available
for all participants, although study resources only permit genotyping 250.
Thus, approximately 250 genotypes are used at each of 30 replications of
each study design. We report results based on the average estimates and
(co)variances. Similar to the simulations, we consider four designs: random
subsampling of 250 children (RS) and three ODS designs. To create the ODS
designs, we first compute all estimated intercepts and slopes from subject-
specific simple linear regressions of post-bronchodilator percent predicted
FVC (FVC%) on time since randomization. Sampling was then based on the
following: the estimated intercept (ods.i), the estimated slope (ods.s), or the
estimated intercept and slope jointly (ods.b). In order to obtain 250 subjects,
the cutoff points that define strata in the ods.i and ods.s designs are given
by the 16th and 84th percentiles of the original cohort. We sampled with
probability 1 subjects at or below the 16th percentile and at or above the
84th percentile, and with probability 0.19 all subjects falling in the central
68% region. For ods.b, we sampled with probability 0.19 all subjects who
fell in the central 68% region of the joint intercept and slope distribution
in the original cohort and with probability 1 all of those falling outside this
region. Table 2 shows the characteristics of the CAMP cohort from which
we subsampled for the ODS studies.
The primary scientific goals of the CAMP analysis are to examine the
treatment effects within subgroups defined by the presence or absence of a
variant allele (VA) on the fourth locus of the IL10 gene, and to examine
the difference in lung growth between those with and without a VA. Three-
way interactions (IL10 × medication × tij) were explored, however, we only
report results from two-way interactions. Thus, the fitted model for this
analysis was
E[yij|Xi] = β0 + β1tij + β2 · bud i + β3 · ned i + β4 · IL10i + β5 · bud i · IL10i
+ β6 · ned i · IL10i + β7 · tij · IL10i + βC · covariates ij.
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Table 2
Demographic and other characteristics of children participating
in the CAMP with genotype and covariate data available.
Continuous variables are summarized with the 10th, 50th and
90th percentiles, and categorical variables other than site are
summarized with proportions
Variable
Cohort size (N) 555
Albuquerque 41
Baltimore 71
Boston 72
Denver 64
San Diego 68
Seattle 80
Saint Louis 91
Toronto 68
Age at randomization (years) 6.23, 8.81, 11.71
Male gender 0.65
Black race 0.10
Other (noncaucasian) race 0.26
Randomized treatment
Placebo 0.50
Budesonide 0.32
Nedocromil 0.17
IL10 variant allele 0.50
Observations per subject 9, 10, 10
Follow-up time (years) 3.85, 3.99, 4.1
Post-bronchodilator percent predicted 92, 105, 116
The covariates that represent the key biomedical questions include the fol-
lowing: the binary time invariant IL10 SNP (snpi); time since randomization
(ti = {ti1, . . . , tini}); Budesonide (bud i) and Nedocromil (ned i) treatments
(with placebo being the reference); and pairwise interactions between IL10
and the other variables. As described in Section 2.4, the imputation ap-
proaches required a model for the predictor of interest, Xei = snpi, in or-
der to impute its value for subjects not selected for the subsample (Si = 0).
Therefore, the CD+MI analysis procedure required estimation of a marginal
exposure distribution (i.e., [Xei|Xoi, Si = 1]), and in that model, race i, sitei,
gender i, bud i and ned i were used as independent variables (Xoi) in an ad-
ditive logistic regression model.
Table 3 shows CAMP regression summaries based on the original cohort
analysis using all subjects (N = 555), and on eight combinations of subsam-
pling designs with and without imputation, where only N ≈ 250 children
were included in a subsample. We provide the key summaries that specif-
ically address the primary research questions, but interested readers may
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Table 3
CAMP results: estimated summaries and standard error estimates (in parentheses) based on 30 replications of each study design. At
each replication, twenty imputation samples were used for the CD+MI analyses. We do not include the standard errors for variance
components with the CD+MI approach because the lme4 package [Bates and Maechler (2010)] does not provide them. Although site
effects are not shown, they were included as fixed effects in regression analyses. The estimated mean row corresponds to the estimated,
end-of-study mean value for the population of white, 12 year old girls, with VAs who were randomized to placebo treatment and who lived
in Baltimore. The original cohort column displays results from the analysis of the full cohort of 555 participants
Variable Original
cohort
RS ods.s ods.i ods.b
CD CD+MI CD CD+MI CD CD+MI CD CD+MI
Primary summaries
Budesomide (vs placebo) at all times
No VAs −2.11 (1.16) −1.57 (1.73) −2.09 (1.46) −3.65 (1.73) −2.92 (1.45) −2.39 (1.41) −2.73 (1.29) −2.65 (1.56) −2.68 (1.34)
With VAs 3.29 (1.24) 3.08 (1.86) 3.08 (1.52) 4.12 (1.92) 4.18 (1.54) 3.99 (1.55) 3.95 (1.38) 3.51 (1.67) 3.69 (1.38)
Difference 5.40 (1.70) 4.65 (2.54) 5.17 (2.43) 7.78 (2.57) 7.10 (2.42) 6.39 (2.10) 6.68 (2.03) 6.16 (2.34) 6.37 (2.10)
Nedocrimil (vs placebo) at all times
No VAs −0.77 (1.17) −0.62 (1.73) −0.56 (1.46) −2.96 (1.73) −1.59 (1.46) −1.11 (1.41) −0.56 (1.24) −2.16 (1.51) −0.96 (1.31)
With VAs 0.69 (1.10) 0.73 (1.63) 0.54 (1.39) 0.42 (1.63) 1.45 (1.36) 0.31 (1.31) 0.64 (1.21) −0.02 (1.36) 0.92 (1.20)
Difference 1.46 (1.61) 1.35 (2.39) 1.10 (2.36) 3.38 (2.41) 3.04 (2.33) 1.42 (1.94) 1.20 (1.87) 2.14 (2.08) 1.88 (1.95)
Time trend (per year) irrespective of treatment
No VAs 0.14 (0.16) 0.11 (0.23) 0.09 (0.19) 0.14 (0.17) 0.10 (0.16) −0.04 (0.22) 0.09 (0.18) 0.19 (0.18) 0.13 (0.17)
With VAs −0.25 (0.15) −0.19 (0.23) −0.19 (0.19) −0.19 (0.17) −0.21 (0.16) −0.38 (0.22) −0.21 (0.18) −0.25 (0.18) −0.24 (0.16)
Difference −0.39 (0.22) −0.30 (0.33) −0.27 (0.31) −0.33 (0.24) −0.31 (0.24) −0.35 (0.31) −0.30 (0.29) −0.44 (0.26) −0.37 (0.25)
IL10 (VA vs no VA) in the placebo arm at baseline and year 4
tij=0 −1.65 (1.15) −1.67 (1.70) −1.78 (1.69) −2.20 (1.65) −2.13 (1.67) −1.72 (1.30) −1.90 (1.32) −1.29 (1.46) −1.50 (1.39)
tij=4 −3.2 (1.17) −2.87 (1.73) −2.88 (1.71) −3.51 (1.68) −3.35 (1.68) −3.11 (1.5) −3.12 (1.52) −3.05 (1.52) −2.98 (1.48)
Estimated mean106.33 (1.51) 106.86 (2.32) 106.47 (1.64) 107.95 (2.20) 106.23 (1.62) 106.69 (1.99) 106.42 (1.63) 106.79 (1.97) 106.47 (1.59)
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Table 3
(Continued)
Variable Original
cohort
RS ods.s ods.i ods.b
CD CD+MI CD CD+MI CD CD+MI CD CD+MI
Other mean model parameters
Male (vs female) −1.14 (0.72) −1.47 (1.08) −1.22 (0.73) −1.47 (1.07) −1.13 (0.72) −0.71 (0.86) −1.16 (0.72) −1.19 (0.90) −1.21 (0.72)
Black (vs white) 0.51 (1.21) 0.52 (1.87) 0.53 (1.25) 1.22 (1.85) 0.76 (1.23) 1.19 (1.56) 0.47 (1.24) 1.88 (1.50) 0.67 (1.23)
Other (vs white) −0.81 (0.98) −0.95 (1.44) −0.74 (0.99) −1.31 (1.44) −0.59 (1.00) −0.01 (1.15) −0.71 (0.99) −0.32 (1.20) −0.61 (0.99)
Age (tij = 0) −0.21 (0.17) −0.23 (0.26) −0.22 (0.17) −0.40 (0.26) −0.23 (0.17) −0.50 (0.21) −0.22 (0.17) −0.39 (0.22) −0.22 (0.17)
Variance components
log(σ0) 2.19 2.18 (0.05) 2.19 2.16 (0.05) 2.18 2.18 (0.04) 2.18 2.18 (0.04) 2.18
log(σ1) 0.84 0.85 (0.06) 0.84 0.84 (0.05) 0.84 0.83 (0.05) 0.84 0.84 (0.05) 0.84
log(1+ρ)
log(1−ρ)
−1.70 −1.13 (0.15) −1.70 −1.06 (0.12) −1.70 −1.11 (0.12) −1.70 −1.08 (0.12) −1.69
log(σe) 1.55 1.54 (0.02) 1.55 1.60 (0.02) 1.55 1.60 (0.02) 1.55 1.62 (0.02) 1.55
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look to online supplementary materials [Schildcrout et al. (2015)] for all
longitudinal model regression estimates and interactions used to generate
the summaries. Specifically, we focus on medication effects and time trends
within subgroups defined by presence or absence of an IL10 variant, the dif-
ference in expected FVC between those with and without an IL10 variant
at baseline (tij = 0) and at the end of the study (tij = 4) for subjects on
placebo treatment, and the end-of-study predicted mean value.
In the original cohort analysis we observed the following associations that
were statistically significant at the α = 0.05 level: (1) for subjects with an
IL10 variant, the expected FVC% was estimated to be 3.29 (1.24) units
higher across all times in those randomized to Budesomide compared to
placebo; (2) the effect of Budesomide compared to placebo was 5.40 (1.70)
units higher in those with an IL10 variant than in those without an IL10
variant; and (3) at the end of the study (tij = 4), those with an IL10 variant
were estimated to have FVC% values that were 3.20 (1.17) units lower than
those without an IL10 variant. Our interest is in the impact of subsampling
design choices, so a natural option to consider is a simple random sample.
However, although the random sampling design produced point estimates
that were similar to results from the original cohort, none of the full cohort-
based associations would be considered statistically significant using the RS
design. In contrast, all ODS designs detected the three significant effects seen
in the original cohort, demonstrating the potential efficiency gains though
use of biased sampling in a resource-limited environment.
Furthermore, for all designs the use of imputation (CD+MI analysis) im-
proved estimation efficiency of key parameters. For example, when sampling
using ods.b, the standard error for the Budesomide versus placebo contrast
was 1.67 under the CD analysis, 1.38 under the CD+MI analysis and 1.24
for the original cohort analysis. Such efficiency gains due to MI were also
observed in all coefficient estimates for the other baseline covariates mea-
sured on all subjects (e.g., age, race and gender). In contrast, and consistent
with simulations, CD+MI did not produce appreciably smaller estimates of
uncertainty than CD analyses for parameters that capture (retrospectively
ascertained) IL10 effects and interactions. For example, under the ods.b de-
sign, the standard error estimate for the IL10 VA association with FVC% in
the placebo arm at tij = 4 was 1.52 and 1.48 with CD and CD+MI analyses,
respectively. Similarly, the standard error estimate for the difference in the
time trends between those with and without the IL10 VA was 0.26 and 0.25
with CD and CD+MI analyses, respectively.
Finally, for many parameters, the combination of subsampling and the
use of imputation was able to recover a large fraction of the information
present in the original cohort but with less than half the cost in terms of
number of subjects for whom covariates would be ascertained. For example,
all estimators produced quite similar estimates of the predicted mean value
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at the end of the study, ranging from 106.33 to 107.95, and the ods.b plus
CD+MI combination estimated the standard error to be 1.59, only slightly
higher than the 1.51 estimated from the original cohort. In summary, the
CAMP analysis illustrates that targeted subsampling is typically more ef-
ficient than simple random sampling, and that using all available data is
also beneficial and can be easily accomplished through imputation of data
for those subjects not selected in a given subsample. We recommend that
future ancillary studies of existing longitudinal cohorts consider the benefits
of directed sampling coupled with efficient analysis.
5. Discussion. The CAMP longitudinal clinical trial was conducted in
an era when genotyping was more expensive than today. Owing to ongo-
ing interest in treatment heterogeneity, it is of interest to examine whether
treatment effectiveness varies across genotype. Because this would be a
secondary aim of most trials, it makes sense economically to conduct the
trial, obtain response trajectories and test for overall treatment effectiveness
first. Depending on what is learned through those primary investigations,
investigators—or their colleagues—may then wish to move ahead with other
exposure assessments to examine exposure effects or treatment-by-exposure
interactions. Such data could be used for confirmatory analyses or, more
likely, for pilot or preliminary data in an exploratory model. In these kinds
of settings, especially, cost effectiveness is critical, and can make the differ-
ence between a study being viable or not.
To address such problems, in this manuscript we discussed novel statistical
approaches to the combination both of ODS designs and of efficient analy-
ses for longitudinal continuous response data. We observed that MI-based
approaches can improve efficiency dramatically over CD analyses for pa-
rameters corresponding to estimation targets involving covariates that were
not imputed (e.g., demographics and the estimated mean value in CAMP).
Efficiency improvements were more modest for the coefficients of imputed co-
variates (e.g., the VA by time interaction under the ods.s design in CAMP),
although such results can be influenced by data features (e.g., effect size
in simulation). Importantly, we also observed that, even when MI is a de-
fault analytical choice, ODS designs can still improve efficiency dramatically
in targets associated (directly or indirectly through interactions) with the
retrospectively ascertained covariate.
Because this manuscript discusses what we believe are new study designs,
we were not able to analyze data directly from such a study. Such studies
have yet to be conducted. Instead, to describe the characteristics of the
designs and estimators, we replicated simulated substudies from CAMP.
While this may not appear to be ideal at first, it allowed us to explore
alternative CAMP substudy designs and did not lock us in to a single design.
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The two MI strategies, CD-MI and D-MI, approach parameter estimation
in somewhat different ways, even in the context of the overall MI framework.
Specifically, both approaches require careful consideration of two model spec-
ifications. Whereas the outcome model [Yi|Xei,Xoi] is common to both
strategies, CD+MI requires the direct specification of a marginal exposure
model [Xei|Xoi] and D-MI requires the direct specification of the fully con-
ditional exposure model [Xei|Xoi,Yi]. We believe that each approach has
an important advantage. In a relative way, CD+MI may be considered ad-
vantageous because the marginal exposure model is likely to be relatively
simple as compared to the conditional exposure model, and so the focus of
analysis with CD+MI is on the outcome model. The conditional exposure
model that is directly specified with D-MI is likely to involve additional
consideration of the functional form of a time-varying (response) variable
toward prediction of a time-fixed exposure variable. In contrast, the D-MI
may be considered more flexible because the outcome and imputation mod-
els are decoupled. As compared to CD+MI, it could potentially be more
robust to misspecification of the outcome model.
Finally, a rigorous evaluation of competing approaches (e.g., inverse prob-
ability weighting) is next in this line of research. A key reason we have not
pursued that here is that we are primarily interested in situations wherein a
full likelihood approach for both estimation and inference is of interest. The
IPW approaches step out of that paradigm, instead relying on sandwich-
type variance estimators, making the comparison among the methods more
complex. Other areas of future research that specifically pertain to the im-
putation approaches involve extensions of the exposure variable to contin-
uous, ordinal and time-varying data. We also intend to explore imbalanced
time-varying covariates, unequal cluster sizes, general patterns of missing
data/dropout, mean model misspecification and imputation model misspec-
ification.
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Supplement A: D-MI Derivation for the model used in simulation (DOI:
10.1214/15-AOAS826SUPPA; .pdf). Derivation of the D-MI imputation mo-
del used in simulations (in Section 2.4.2).
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(DOI: 10.1214/15-AOAS826SUPPB; .pdf). Results from the CAMP anal-
ysis that were used to derive the summaries in Table 3.
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